TrialInternational journal of hematology2009

Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma.

Hirokazu Murakami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.